Peripheral Vascular Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Peripheral Vascular Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Peripheral Vascular Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Peripheral Vascular Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Peripheral vascular devices include the devices used to treat peripheral vascular disease (PVD).
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Peripheral Vascular Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Peripheral Vascular Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Peripheral Vascular Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Peripheral Vascular Devices Overview
Products under Development
Peripheral Vascular Devices - Pipeline Products by Stage of Development
Table Peripheral Vascular Devices - Pipeline Products by Stage of Development
Table Peripheral Vascular Devices - Pipeline Products by Stage of Development
Peripheral Vascular Devices - Pipeline Products by Segment
Table Peripheral Vascular Devices - Pipeline Products by Segment
Table Peripheral Vascular Devices - Pipeline Products by Segment
Peripheral Vascular Devices - Pipeline Products by Territory
Table Peripheral Vascular Devices - Pipeline Products by Territory
Table Peripheral Vascular Devices - Pipeline Products by Territory
Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Table Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Table Peripheral Vascular Devices - Pipeline Products by Regulatory Path
Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Table Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Table Peripheral Vascular Devices - Pipeline Products by Estimated Approval Date
Table Peregrine System Kit - Hypertension - A Phase II, Multicenter, Blinded, Sham Procedure-controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, in the Absence of Antihypertensive Medications
Table Peregrine System Kit - Hypertension - A Pivotal, Multicenter, Blinded, Sham procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension
Table Acotec Scientific Co Ltd - Ongoing Clinical Trials Overview
Table AcoArt-Litos Drug-Eluting Balloon - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table AcoArt-Litos Drug-Eluting Balloon - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table AcoArt-Litos Drug-Eluting Balloon - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Table AcoArt-Tulip - A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery
Table AcoArt-Tulip - All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment
Table Spot Stent System - A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries
Adept Medical Ltd Company Overview
Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Natural Vascular Scaffolding Device - A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF
Table Natural Vascular Scaffolding Device - Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I
Table Natural Vascular Scaffolding Device - Study to Evaluate the Safety and Efficacy of the Alucent Natural Vascular Scaffolding (Alucentnvs) Vessel Restoration System with Photoactivated Linking in the Treatment of Peripheral Artery Disease (PAD) of the Lower Extremities
amg International GmbH Company Overview
amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table Amplitude Vascular Systems Inc - Ongoing Clinical Trials Overview
Table Pulse Intravascular Lithotripsy System - Peripheral Arterial Disease - A Prospective, Single-Arm, Multicenter, Feasibility Study to Evaluate Safety and Performance of the Amplitude Vascular System (AVS) Pulse Peripheral Intravascular Lithotripsy (IVL) for Treating Subjects With Calcific Femoropopliteal Arteries in Conjunction With Adjunctive Therapy
Table Distal Embolic Protection System - Product Status
Table Distal Embolic Protection System - Product Description
Table SPG Guidewire - Product Status
Table SPG Guidewire - Product Description
Table Thrombolytic Catheter - Product Status
Table Thrombolytic Catheter - Product Description
Table Transjugular Intrahepatic Puncture System - Product Status
Table Transjugular Intrahepatic Puncture System - Product Description
Table APT Medical Inc - Ongoing Clinical Trials Overview
Table Transjugular Intrahepatic Puncture System - A Prospective Multicenter, Single-Arm Clinical Trial to Evaluate the Efficacy of a Covered Stent To Treat Portal Hypertension Complications in the TIPS (Transjugular Intrahepatic Portosystemic Shunt)
Table BD Sirolimus Drug Coated Balloon Catheter - Product Status
Table BD Sirolimus Drug Coated Balloon Catheter - Product Description
Table Becton Dickinson and Co - Ongoing Clinical Trials Overview
Table BD Sirolimus Drug Coated Balloon Catheter - A Prospective, Multicenter, Single Arm, Non-Randomized, Study to Assess the Performance and Safety of BD Sirolimus Drug Coated Balloon Catheter for Treatment of Femoropopliteal Arteries
Table BD Liverty TIPS Stent Graft - A Global, Prospective, Multi-center, Single-arm Clinical Study for the Treatment of Complications from Portal Hypertension, Assessing the Safety and Effectiveness of the Investigational BD Liverty TIPS Stent Graft
Ben-Gurion University of the Negev Company Overview
Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
Table Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
Table Clot Retrieval Electrode Catheter - Product Status
Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
Table Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
Table Oscar Peripheral Multifunctional Catheter System - Product Status
Table Oscar Peripheral Multifunctional Catheter System - Product Description
Biotyx Medical (Shenzhen) Co Ltd Company Overview
Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table IBS Titan - Product Status
Table IBS Titan - Product Description
Table Biotyx Medical (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table IBS Titan - A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL
Table IBS Titan - A Prospective, Multicentre, Single Arm Clinical Trial to Assess the Safety and Effectiveness of Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan) in Treating Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
Boston Scientific Corp Company Overview
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table Boston Scientific Corp - Ongoing Clinical Trials Overview
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - A Prospective, Single-Centre Study Investigating the Clinical Use and Safety of the Jetstream Atherectomy With Drug Coated Balloon (Ranger) for the Treatment of Dysfunctional Arterio-Venous Graft Stenosis
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drugcoated Balloon for Complex Femoropopliteal Artery Disease (ARTEMIS Trial)
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): "Real Life" Observational Study
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
Table Ranger Paclitaxel-Coated PTA Balloon Catheter - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Table Cardiva Medical Inc - Ongoing Clinical Trials Overview
Table VASCADE MVP System - A Multi-center, Prospective, Single Arm Registry to Evaluate Procedural Outcomes Using the Cardiva VASCADE MVP VVCS Closure Device after Catheter-based Atrial Fibrillation Interventions for Patients Who Are Discharged the Same Day
Catharos Medical Systems Inc Company Overview
Catharos Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Catharos Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Peripheral Everolimus Drug-Coated Balloon - A First in-human Study Evaluating the Efficacy of Peripheral Everolimus Drugcoated Balloon in Patients with Peripheral Artery Disease: CVT-SFA
Table Concept Medical Inc - Ongoing Clinical Trials Overview
Table MagicTouch PTA Balloon Catheter - Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Table MagicTouch PTA Balloon Catheter - Head-to-Head Comparison of Sirolimus Versus Paclitaxel Drug-Eluting Balloon Angioplasty in the Femoropopliteal Artery
Table MagicTouch PTA Balloon Catheter - Major Adverse Limb Events in Patients with Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated with Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
Table MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First SirolimUs Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease: FUTURE BTK
Table MagicTouch PTA Balloon Catheter - Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Superficial Femoral Artery and Popliteal Artery Disease
Contego Medical LLC Company Overview
Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table Tibial Artery Drug Eluting Balloon - Product Status
Table Tibial Artery Drug Eluting Balloon - Product Description
Table Contego Medical LLC - Ongoing Clinical Trials Overview
Table Neuroguard IEP System - Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent II
Table Neuroguard IEP System - Protection Against Emboli During caRotid Artery Stenting Using a Neuroguard IEP® Direct 3-in-1 Delivery System Comprised oF a pOst-dilation Balloon, integRated eMbolic Filter, and A Novel Carotid stEnt – the PERFORMANCE III Study
Cook Medical Inc Company Overview
Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Cook Medical Inc - Ongoing Clinical Trials Overview
Table Zenith Connection Endovascular Covered Stent - The Enzen Trial: Comparison of EVAR Outcomes With Endurant Versus Zenith Endoprosthesis: a Prospective Analysis.
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Intervention with Selution SLR Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Pivotal Clinical Trial for the Treatment of Occlusive Disease of the Superficial Femoral Artery (SFA) Using SELUTION SLR Sirolimus-eluting Balloon
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Prospective Registry to Investigate the Safety and Efficacy of the Treatment with the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-inguinal Disease in Patients with Chronic Limb Threatening Ischemia from Singapore
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SELUTION SLR 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis
Table SELUTION SLR 018 DEB - Peripheral Artery Disease - SUCCESS (Selution, Safety, Efficacy, Health Economics and Proms) PTA Study
CorInnova, Inc. Company Overview
CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Efemoral Vascular Scaffold System (EVSS) - Product Status
Table Efemoral Vascular Scaffold System (EVSS) - Product Description
Table Efemoral Medical LLC - Ongoing Clinical Trials Overview
Table Efemoral Vascular Scaffold System (EVSS) - A Clinical Evaluation of the Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
Table SureClose Vascular Closure Device - Clinical First in Man Study of the Safety and Performance of the Genesis Medtech Innovation Private Limited Sureclose Vascular Closure Device (VCD) for use In Closing Femoral Access Sites
George Washington University Company Overview
George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table Rhythmic Cuff - Product Status
Table Rhythmic Cuff - Product Description
Gradient Denervation Technologies Company Overview
Table Minimally Invasive Device - Pulmonary Hypertension - A First-In-Human Study of Pulmonary Artery Denervation Technology
Table Minimally Invasive Device - Pulmonary Hypertension - An Early Feasibility Study of Pulmonary Artery Denervation Technology
Table Minimally Invasive Device - Pulmonary Hypertension - Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients with Pulmonary Hypertension
Table Minimally Invasive Device - Pulmonary Hypertension - Pulmonary Artery Denervation Clinical Study Using the Gradient Denervation System in Heart Failure Patients with Pulmonary Hypertension Group 2 (PreVail-PH2 Study)
Guerbet SA Company Overview
Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview
Table Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview
Table Microguidewire - Product Status
Table Microguidewire - Product Description
Table SeQure - Product Status
Table SeQure - Product Description
Table Ultra Hi-Flow Microcatheter - Product Status
Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table PADview - Product Status
Table PADview - Product Description
Handok-Kalos Medical Company Overview
Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
Table Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
Table DENEX - Product Status
Table DENEX - Product Description
Table Handok-Kalos Medical - Ongoing Clinical Trials Overview
Table DENEX - A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients with Hypertension on no or 1-3 Antihypertensive Medications
Table DENEX - A Prospective, Multicenter, Sham-controlled, Single-blinded, Randomized, Pilot Study to Evaluate the Safety and Effectiveness of DENEX Renal Denervation System in Patients With Uncontrolled Hypertension Not Treated With Anti-HTN Medication
Table EMBLOK Embolic Protection System - A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK Embolic Protection System During Transcatheter Aortic Valve Replacement
Table EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Innovein Medical Inc Company Overview
Innovein Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table CGuard Embolic Prevention System - A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
Table CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronetcovered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
Table CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
Table CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
Table CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
Table CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
Table Embrace Hydrogel Embolic System - A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries
Table Embrace Hydrogel Embolic System - Randomized Multi-center, Subject and Evaluator Blinded, Parallel-group Study to Evaluate the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) Compared with Standard of Care Transcatheter Arterial Embolization (TAE) / Transcatheter Arterial Chemoembolization (cTACE) for Vascular Occlusion of Hypervascular Tumors: A Pivotal Study
International Cardio Corp Company Overview
International Cardio Corp Pipeline Products & Ongoing Clinical Trials Overview
Table FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
LimFlow SA Company Overview
LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview
Table LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview
Table LimFlow Percutaneous Deep Vein Arterialisation System - Product Status
Table LimFlow Percutaneous Deep Vein Arterialisation System - Product Description
Table LimFlow SA - Ongoing Clinical Trials Overview
Table LimFlow Percutaneous Deep Vein Arterialisation System - Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
Table LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Latestage Chronic Limb-threatening Ischemia: The PROMISE II Trial
Table LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late- Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
Table LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
Table LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
Table Symplicity Renal Denervation System - Renal Denervation in Patients with Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation (REDE-AF): A National, Multi-Centre, Prospective, Single-arm, Pre-to-post Treatment, Medical- Device Study
Table Symplicity Renal Denervation System - Study Evaluating the Clinical Evidence of Symplicity Renal Denervation System in Subjects with Uncontrolled Hypertension
Table Symplicity Spyral Renal Denervation System - Cardiac Sympathetic Neuromodulation by Renal Denervation in Hypertrophic Cardiomyopathy (SNYPER Pilot Study)
Table Symplicity Spyral Renal Denervation System - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multielectrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTNON MED)
Table Symplicity Spyral Renal Denervation System - Prairie Renal Denervation Study: Renal Denervation (RDN) for Management of Patients with Loin Pain Hematuria Syndrome (LPHS)
Table Symplicity Spyral Renal Denervation System - Renal Nerve Simulation Guided Renal Sympathetic Denervation with Siymplicity Spyral Radiofrequency Catheter for Resistant Hypertension: a Feasibility Study
Table Symplicity Spyral Renal Denervation System - The SPYRAL AFFIRM Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM)
Table Symplicity Spyral Renal Denervation System - The Systemic Effects of Transcatheter Renal Artery Sympathetic Denervation Using a Second- Generation Radiofrequency Ablation Catheter: A Multicenter Observational Study.
Table IN.PACT Admiral DEB - BTK - Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries
Table Bullfrog Micro-Infusion Device - Below The Knee - Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes below the Knee: TANGO
Table Bullfrog Micro-Infusion Device - Below The Knee - Temsirolimus Alone or Paired with Dexamethasone Delivered to the Adventitia to Enhance Clinical Efficacy after Femoropopliteal Revascularization
Table Melange BRS - A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery
Table FlashPoint Renal Artery RF Ablation Catheter - 3D Cardiac Electrophysiological Mapping System on Renal Artery Radiofrequency Ablation System for Hypertension: a Prospective, Multicenter, Randomized Controlled Trial
Table Neonav ECG Tip Location System - NeoNav ECHO Study: Electrocardiogram (ECG) waveforms associated with central venous catheter tip position (of catheters placed in babies) as verified by echocardiography (ECHO)
Navis Medical Company Overview
Navis Medical Pipeline Products & Ongoing Clinical Trials Overview
Table Navis Medical Pipeline Products & Ongoing Clinical Trials Overview
Table Variable Control Guidewire System - Product Status
Table Variable Control Guidewire System - Product Description
Table Praxis Medical Devices Ltd - Ongoing Clinical Trials Overview
Table CapBuster - A Non-Randomized Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions
Table CapBuster - A Non-Randomized Clinical Study Evaluating Use of the CapBuster System Medical Device for the Crossing of Chronic Total Occlusions in Coronary Arteries
Table MAGNITUDE Bioresorbable Drug-Eluting Scaffold - Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
Table MAGNITUDE Bioresorbable Drug-Eluting Scaffold - Evaluation of the MAGNITUDE Bioresorbable Drug-Eluting Scaffold (BRS) in the Treatment of Patients With Below the Knee Disease in Australia
Table MAGNITUDE Bioresorbable Drug-Eluting Scaffold - The R3 Vascular Drug-eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)
Table Temporary Spur Stent System - Product Status
Table Temporary Spur Stent System - Product Description
Table Reflow Medical, Inc. - Ongoing Clinical Trials Overview
Table Temporary Spur Stent System - A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States
Table Temporary Spur Stent System - A Pilot Study of the Drug-eluting Coronary Spur Stent as a Primary Treatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)
Table Temporary Spur Stent System - A Prospective Single-Arm Multicenter Study of the Bare Temporary Spur Stent System for the Treatment of Vascular Lesions Located in the Infrapopliteal Arteries Below the Knee (DEEPER REVEAL)
Table Temporary Spur Stent System - A Randomized Controlled Trial of the Drug Eluting Temporary Spur Stent System Vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
Table REVA Medical Inc - Ongoing Clinical Trials Overview
Table MOTIV Bioresorbable Scaffold - A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared With Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions
Table MOTIV Bioresorbable Scaffold - Physician-initiated Trial Investigating the MOTIV Bioresorbable Scaffold (Reva Medical) for the Treatment of Below-the-knee Artery Disease
Rex Medical LP Company Overview
Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
Table Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
Table Auto-Close Vascular Sealing System - Product Status
Table Auto-Close Vascular Sealing System - Product Description
Table Large Bore Closer Vascular Sealing System - Product Status
Table Large Bore Closer Vascular Sealing System - Product Description
Rontis AG Company Overview
Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
Table Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
Table Peripheral Guidewire - 0.035 - Product Status
Table Shanghai Changde Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table Below-The-Knee Rapamycin Drug Coated Balloon - To Evaluate the Safety and Efficacy of Drug-eluting Below-the-knee Balloon Dilatation Catheter in the Treatment of Infrapopliteal Artery Stenosis or Occlusion in a Prospective, Multicenter, Randomized Controlled Clinical Trial
Shanghai Golden Leaf Medtech Co Ltd Company Overview
Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Renal Denervation System - Hypertension - Product Status
Table Renal Denervation System - Hypertension - Product Description
Shanghai Healing Medical Instruments Co Ltd Company Overview
Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Super-Stiff Guidewire - Product Status
Table Super-Stiff Guidewire - Product Description
Shanghai HeartCare Medical Technology Co Ltd Company Overview
Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent - A Multicenter, Randomized, Controlled, Superiority Clinical Trial to Evaluate the Safety and Efficacy of Drug-eluting Peripheral Arterial Stent System(G-stream) in the Treatment of the Above-the-knee Femoropopliteal Artery Stenosis or Occlusion
Shockwave Medical Inc Company Overview
Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Therapeutic Intra-Vascular Ultrasound (TIVUS) System - Renal Artery Denervation - Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS) System for Renal Denervation in Patients with Uncontrolled Stage 2 Hypertension
Table Sundance BTK DCB - A Prospective, Multi-center, Single-arm, Feasibility Study to Assess the Safety and Performance with the SUNDANCE DruG Coated Balloon for the Treatment of De Novo or Restenotic Lesions in Infra-popliteal Arteries
Suzhou Rainmed Medical Technology Co Ltd Company Overview
Suzhou Rainmed Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Suzhou Rainmed Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Flash RDN System - Product Status
Table Flash RDN System - Product Description
Suzhou Xinmai Medical Equipment Co Ltd Company Overview
Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table SyMapCath I Catheter - Product Status
Table SyMapCath I Catheter - Product Description
Table SYMPIONEER S1 Mapping System - Product Status
Table SYMPIONEER S1 Mapping System - Product Description
Table Suzhou Xinmai Medical Equipment Co Ltd - Ongoing Clinical Trials Overview
Table SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial)
Table SyMapCath I Catheter - A Prospective, Single-center, Open-label, Self Controlled Case Series Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension in Patients on Hemodialysis: SMART-HD Trial
Suzhou Yinluo Medical Devices Co Ltd Company Overview
Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Iliac Vein Stent - Product Status
Table Iliac Vein Stent - Product Description
Suzhou Zhonghui Medical Technology Co Ltd Company Overview
Suzhou Zhonghui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Suzhou Zhonghui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table C-wave Peripheral Seismic Waveguide System - Product Status
Table C-wave Peripheral Seismic Waveguide System - Product Description
Table Suzhou Zhonghui Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table C-wave Peripheral Seismic Waveguide System - Efficacy and Safety Trial of C-wave™ Peripheral Lithoclasty Catheter System in Peripheral Arterial Angioplasty
Table MISAGO RX Self-Expanding Stent System - Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External ILIAC Artery using the Misago Rx Self-expanding Peripheral Stent:OSPREY ILIAC
Terumo Interventional Systems Company Overview
Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
Table Verve Medical Phoenix System - Product Status
Table Verve Medical Phoenix System - Product Description
Table Verve Medical, Inc. - Ongoing Clinical Trials Overview
Table Verve Medical Phoenix System - Natural Orifice via Renal Pelvis Denervation (Novel- Denervation) Pivotal IDE Trial for the Treatment of Uncontrolled Hypertension to Lower Blood Pressure
Table Verve Medical Phoenix System - Trans Ureteral Sympathectomy of the Kidney Study Using the Verve Medical Phoenix System
Veryan Medical Ltd Company Overview
Veryan Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Vesper Duo Venous Stent System - Product Status
Table Vesper Duo Venous Stent System - Product Description
Table Vesper Medical Inc - Ongoing Clinical Trials Overview
Table Vesper Duo Venous Stent System - Prospective, Single-centre Post-Market Clinical Follow-up (PMCF) Study to Evaluate Safety and Performance of the DUO Venous Stent
Table Vesper Duo Venous Stent System - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
Table Vivasure Medical Ltd. - Ongoing Clinical Trials Overview
Table PerQseal - A Multicentre, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the Vivasure PerQseal Closure Device System When Used to Achieve Haemostasis of Common Femoral Arteriotomies Created by 12 to 22 F Sheaths in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures
Table PerQseal+ - An Early Feasibility Study Evaluating the Safety and Efficacy of PerQseal+ in Patients Undergoing Percutaneous Transcatheter Aortic Valve Replacement Procedures
Table PerQseal+ - Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
Table PerQseal+ - Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study (France)
VueKlar Cardiovascular Ltd (Inactive) Company Overview
W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
Table W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
Table GORE VIAFORT Vascular Stent - Product Status
Table GORE VIAFORT Vascular Stent - Product Description
Table W. L. Gore & Associates Inc - Ongoing Clinical Trials Overview
Table GORE VIAFORT Vascular Stent - Evaluation of the GORE VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction
Table GORE VIAFORT Vascular Stent - Evaluation of the GORE VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction
Wake Forest University Health Sciences Company Overview
Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table Vascular Stent - Product Status
Table Vascular Stent - Product Description
Weill Cornell Medical College Company Overview
Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
Table Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
Table Zone Isolation and Bypass System - Product Status
Table Zone Isolation and Bypass System - Product Description
Table Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table ZENFLEX Pro Peripheral Drug Eluting Stent System - Swedish Drug-elution Trial in Peripheral Arterial Disease - A Multicenter, Prospective Randomized Controlled Clinical Trial Based on the Swedish Vascular Registry (SWEDVASC) Platform
Table Ultrafree Drug Coated PTA Balloon Catheter - BTK - A Prospective, Multicenter, Randomized Controlled Trail Using Drugcoated Balloon to Treat Below The Knee Arterial Stenosis or Occlusion
Table Ultrafree Drug Coated PTA Balloon Catheter - Dialysis Access - Study to Evaluate the Safety and Efficacy of Ultrafree Drug Coated PTA Balloon Catheter for Dialysis Access
Table Suture-Mediated Closure System - A Prospective, Multi-center, Randomized Controlled, Non-inferiority Clinical Trial of the Safety and Efficacy of the Suture-Mediated Closure System for Percutaneous Closure of the Common Femoral Artery Puncture Site
Table Suture-Mediated Closure System - Multi-center, Randomized and Non-inferiority Clinical Trial to Assess Efficacy and Safety of Suture-mediated Closure system
Table Vascular Closure System - Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture: A Prospective, Multicenter, Randomized Controlled, Non-inferiority Trial
Table ZENFLEX Pinto Spot Stent System - A Prospective, Multicenter, Randomized Controlled Trail Using Spot Stenting to Treat Lower Extremity Post-angioplasty Dissection
Peripheral Vascular Devices- Recent Developments
Dec 14, 2023: Anoxia Medical Receives FDA 510(k) Clearance for Slinky Catheter
Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
Dec 11, 2023: Becton Dickinson Receives Additional 510(K) Clearance For BD Nexiva Diffusics Closed IV Catheter System
Dec 11, 2023: Boston Scientific Receives Additional 510(K) Clearance For iSLEEVE Introducer Set
Dec 11, 2023: Terumo Medical Corporation's New AZUR HydroPack Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy
Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 06, 2023: Micro Medical Solutions Announces Completion of Enrollment in the STAND Pivotal Clinical Trial
Dec 05, 2023: Teleflex Awarded Peripheral Access Agreement with Premier
Dec 01, 2023: Japan Lifeline Announces Changes in Organization and Personnel
Nov 30, 2023: Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
Nov 30, 2023: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
Nov 28, 2023: Medtronic Obtains Pre-Market Approval (PMA) For Symplicity Spyral Renal Denervation System
Nov 28, 2023: First Patient Treated With Medtronic Symplicity Spyral Renal Denervation System at Piedmont
Nov 27, 2023: Inspiremd Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of Cguard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
Nov 21, 2023: BD Names Dr. Ronald Silverman as Chief Medical Officer
Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
Nov 16, 2023: ReCor Medical Obtains Pre-Market Approval (PMA) for Paradise Ultrasound Renal Denervation System
Nov 16, 2023: Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
Nov 16, 2023: Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Nov 16, 2023: enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium
Nov 16, 2023: RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
Nov 15, 2023: New Published Study Demonstrates Safety and Feasibility of Filterlex Medical's CAPTIS Device in Providing Embolic Protection During TAVR
Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
Nov 13, 2023: Recor Medical introduces Paradise uRDN system in US
Nov 13, 2023: One-Year Results from the AAA-SHAPE Early Feasibility Study to be Presented at VEITH 2023
Nov 10, 2023: Microport Appointment of Director
Nov 08, 2023: Recor Medical receives FDA approval for hypertension treatment system
Nov 08, 2023: VentureMed Receives Transitional Pass-Through Payment (TPT) for FLEX Vessel Prep System
Nov 07, 2023: Alucent Biomedical Receives Regulatory Approval for Second U.S. Clinical Study
Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook
Nov 01, 2023: Embolx and Girlow USA Join Forces to Expand Distribution into South America
Nov 01, 2023: Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
Nov 01, 2023: Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial
Nov 01, 2023: Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23
Oct 31, 2023: First Round of Late-Breaking Clinical Trial Results Announced at VIVA23
Oct 31, 2023: Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23
Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15
Oct 30, 2023: Sirtex Medical launches new liquid embolic system
Oct 30, 2023: Filmecc Receives 510(K) Clearance For VASSALLO GT Crossing14 Guide Wire
Oct 30, 2023: Filmecc Receives 510(K) Clearance For VASSALLO GT 018 G12 Peripheral Guide Wire
Oct 30, 2023: Filmecc Receives 510(K) Clearance For VASSALLO GT 018 G30 Peripheral Guide Wire
Oct 27, 2023: Positive six-month follow-up results for Recor’s renal denervation system
Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
Oct 26, 2023: enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Oct 26, 2023: Integer Holdings Reports Third Quarter 2023 Results
Oct 26, 2023: Avinger Reports Third Quarter 2023 Results
Oct 25, 2023: Late-Breaking Data Show Esprit BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care
Oct 20, 2023: Recor Medical to Present Latest Clinical Data on Paradise Ultrasound Renal Denervation at TCT Annual Meeting
Oct 19, 2023: Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
Oct 19, 2023: New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
Oct 17, 2023: Johnson & Johnson Reports Q3 2023 Results
Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations
Oct 16, 2023: Cordis Issues Statement on the CMS Announcement to Expand Coverage of Carotid Stenting
Oct 15, 2023: Shanghai Kindly Medical Instruments Co. Notice of 2023 First Extraordinary General Meeting
Oct 12, 2023: Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
Oct 10, 2023: Becton Dickinson and Co Receives Additional 510(k) Clearance for Nexiva Closed IV Catheter System
Oct 10, 2023: Silk Road Medical Announces Retirement of CEO Erica Rogers
Oct 10, 2023: Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
Oct 09, 2023: enVVeno Medical unveils plans to expedite enVVe valve development
Oct 09, 2023: Contego Medical enrols first patient in Neuroguard IEPsystem trial
Oct 09, 2023: Stryker to Host Investor Day
Oct 06, 2023: enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial
Oct 05, 2023: Shanghai Kindly Medical Instruments Co. Announces 2022 Annual Report
Oct 05, 2023: Ontogen Medtech Secures Illinois $50K Sbir Matching Grant to Advance Partnership With Flow Medical on Groundbreaking Pulmonary Embolism Catheter Device
Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer
Oct 02, 2023: LimFlow Obtains Pre-Market Approval (PMA) for LimFlow System
Oct 02, 2023: Leading Ob/Gyn Performs 100th High Risk Placenta Accreta Case With New Device to Manage Hemorrhage
Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
Sep 28, 2023: Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023
Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
Sep 15, 2023: MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
Sep 14, 2023: BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months
Sep 12, 2023: FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
Sep 11, 2023: Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
Sep 08, 2023: Shape Memory obtains IDE approval for IMPEDE-FX RapidFill device trial
Sep 07, 2023: VentureMed’s FLEX system obtains European MDR Certification
Sep 07, 2023: Endologix Announces the U. S. Centers for Medicare & Medicaid Services Granted a New Technology Add-on Payment for the DETOUR System
Sep 06, 2023: Acotec Scientific : Voluntary Announcement Approval for Microcatheter Vericor-14 By the Ministry of Health, Labour and Welfare in Japan and Food and Drug Administration of Thailand
Sep 01, 2023: MicroPort Endovastec Achieves Its First Clinical Implantation of Reewarm PTX DCB Catheter in Brazil
Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel
Aug 31, 2023: InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23
Aug 30, 2023: Bayer Announces Key Leadership Changes
Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System
Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
Aug 29, 2023: Bayer Announces Leadership Changes
Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
Aug 27, 2023: Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 24, 2023: Endologix Announces that Lucas Buchanan Joins Board of Directors
Aug 23, 2023: Boston Scientific Receives 510(k) Clearance for Rubicon Control Support Catheter
Aug 23, 2023: Medtronic Issues Statement on the FDA Circulatory Systems Devices Advisory Panel Vote for the Symplicity Spyral Renal Denervation System
Aug 23, 2023: Zylox-tonbridge Medical Technology Co. Announces Interim Results for the Six Months Ended June 30, 2023
Aug 23, 2023: BD to Present at Investor Healthcare Conferences
Aug 22, 2023: Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
Aug 21, 2023: Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
Aug 21, 2023: Tissue Regenix Group Notice of Interim Results
Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
Aug 16, 2023: Scientia Vascular Receives Additional 510(k) Clearance for Aristotle Guidewire
Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
Aug 10, 2023: Terumo Medical Receives 510(k) Clearance for R2P Navicross Catheter
Aug 10, 2023: BD Initiates Study to Further Advance the Treatment of Portal Hypertension
Aug 10, 2023: BD Initiates Study to Further Advance the Treatment of Portal Hypertension
Aug 08, 2023: Bayer Reports Half-Year Financial Report 2023
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Aug 07, 2023: MCRA Aids Surmodics in Obtaining FDA Pre-market Approval for Cardiovascular Drug-Coated Balloon
Aug 03, 2023: FDA greenlights light-activated device for use in vascular disease trial
Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook
Aug 01, 2023: Cardinal Health Obtains Pre-Market Approval (PMA) for Palmaz-Mullins XD
Jul 31, 2023: RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
Jul 25, 2023: Johnson & Johnson Medtech India Appoints Anuj Virmani as Managing Director
Jul 21, 2023: Medtronic Statement on the Safety of Paclitaxel Coated Devices to Treat Peripheral Arterial Disease
Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
Jul 18, 2023: Endologix Announces First Patients Treated with the DETOUR System, Advancing Treatment for Complex Peripheral Artery Disease
Jul 17, 2023: Ablative Solutions Receives 510(k) Clearance for Peregrine System Infusion Catheter 3-7 mm
Jul 14, 2023: ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension
Jul 13, 2023: Boston Scientific Scimed Receives 510(k) Clearance for Embold Fibered Coil
Jul 13, 2023: BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon
Jul 11, 2023: Verve Medical Announces FDA Approval of Ide for Pivotal Trial of RPD Renal Pelvic Denervation System for Treatment of Uncontrolled Hypertension
Jul 11, 2023: Cagent Vascular Announces Initial Recoil Study Results: Serranator Demonstrates 49% Less Recoil Than Poba in BTK Arteries
Jul 11, 2023: Semler Scientific Announces Appointment of Cormier as Chief Financial Officer
Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
Jul 11, 2023: UPDATE: Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality - Letter to Health Care Providers
Jul 03, 2023: Medtronic Statement on ESH Guidelines for Hypertension and Renal Denervation
Jun 30, 2023: Bioheart Announces Clinical Result for Iberis-HTN at CIT 2023
Jun 30, 2023: LifeTech Scientific Announces 2023 Interim Results
Jun 29, 2023: Advance Serenity PTA Balloon Now Available in More Sizes and Locations
Jun 27, 2023: Kalos Medical Receives Korean MFDS Innovative Medical Device Designation for DENEX Hypertension Treatment System
Jun 26, 2023: Second Cook-Sponsored Animal Study Showcases Unique Imaging Methodology and Reveals New Data on Fibered Versus Nonfibered Embolization Coils
Jun 21, 2023: VVT Medical receives FDA 510(k) clearance for its ScleroSafe System
Jun 16, 2023: Guerbet Receives 510(k) Clearance for DraKon
Jun 15, 2023: Summa Therapeutics Receives 510(k) Clearance for Finesse Injectable PTA Balloon Dilatation Catheter
Jun 13, 2023: Gore Initiates Study to Compare the Gore Viabahn Vbx Balloon Expandable Endoprosthesis to Bare Metal Stents
Jun 12, 2023: DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at Six Months
Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
Jun 11, 2023: Boston Scientific Position on FDA Update About Use of Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease
Jun 08, 2023: Endologix Receives FDA Approval of the Detour System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients With Pad
Jun 07, 2023: Optimized for Crossing Venous and Arterial Occlusions: Tunnel Crossing Catheter Receives US FDA 510(k) Clearance
Jun 07, 2023: Endovastec Participates in the Congresso International de Cirurgia Endovascular
Jun 06, 2023: Zylox-tonbridge Medical Technology Co. Announces Poll Results of the 2022 Annual General Meeting
Jun 03, 2023: Chinese renal denervation trial adds more evidence to hypertension treatment option
Jun 01, 2023: Gradient Denervation Technologies enrolls initial patient in first-in-human study of Pulmonary Artery Denervation Technology
May 30, 2023: Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
May 30, 2023: Shape Memory Medical announces publication of study results in Vascular
May 24, 2023: EOsolutions announces the full commercial launch of the Dr. Banner Balloon Guide Catheter: a breakthrough balloon guide catheter with unmatched features for neurovascular procedures
May 19, 2023: EuroPCR 2023 | 6 month outcome of the SMART study: satisfactory BP control achieved with reduced medication burden
May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend
May 16, 2023: Inari Medical receives additional 510(k) clearance for Artix Ballon Guiding Sheath
May 16, 2023: PAVmed provides business update and Q1 financial results
May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023
May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
May 10, 2023: Wallaby Medical receives 510(k) clearance for 017 Micro Catheter
May 09, 2023: Emboline announces first patient treated in IDE study of Emboliner Full-Body Embolic Protection Catheter to minimize stroke risk From TAVR
May 06, 2023: MicroVention receives 510(k) clearance for Nanoparasol Embolic Protection System
May 05, 2023: PAVmed to hold a business update conference call and webcast on May 17, 2023
May 04, 2023: Vivasure recruits first patients in PerQseal closure device trial
May 04, 2023: Cordis receives 510(k) clearance for RAIN Sheath Tibial Pedal Introducer
May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
May 03, 2023: Terumo receives 510(k) clearance for EmPro Embolic Protection System
May 03, 2023: Kalos Medical announces grant award, completion of patient recruitment of clinical trial
May 03, 2023: Inari Medical reports First Quarter 2023 financial results
May 02, 2023: LeMaitre Q1 2023 financial results
Apr 28, 2023: Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
Apr 27, 2023: Integer Holdings reports First Quarter 2023 results
Apr 26, 2023: Silk Road Medical receives additional 510(k) clearance for Enroute Transcarotid Neuroprotection System
Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023
Apr 26, 2023: MicroPort announces annual results for 2022
Apr 24, 2023: SkyDance Vascular receives 510(k) Approval for OSPREY PERIPHERAL IV Catheter System
Apr 20, 2023: Dingke Medical Technology (Suzhou) receives 510(k) clearance for D·Kaptain PTA High Pressure Balloon Dilatation Catheter
Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
Apr 19, 2023: Surmodics announces successful first patient use of Sublime Radial Access Microcatheter designed for the periphery
Apr 18, 2023: BlackSwan Vascular wins FDA premarket approval of innovative new treatment for peripheral arterial hemorrhages
Apr 18, 2023: Johnson & Johnson Reports Q1 2023 Results
Apr 13, 2023: Inari Medical to Announce First Quarter 2023 Financial Results
Apr 12, 2023: Ablative Solutions, announces enrollment completion of TARGET BP I study for patients with uncontrolled hypertension
Apr 12, 2023: Medtronic has a layoff in California
Apr 11, 2023: J&J talc unit 2nd bankruptcy must be dismissed
Apr 06, 2023: Regulator grants valvuloplasty catheter rare medical device status for aortic valve stenosis
Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
Apr 04, 2023: BioCardia announces issuance of two patents related to technology that guides interventional therapies
Mar 30, 2023: Filmecc receives 510(k) clearance for Vassallo GT 018 Hybrid Guide Wire
Mar 30, 2023: LimFlow reports positive data from LimFlow System trial
Mar 30, 2023: Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million
Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format
Mar 28, 2023: Surmodics provides regulatory update on its strategy to submit an amended Premarket Approval Application for the SurVeil Drug-Coated Balloon
Mar 28, 2023: GORE announces first U.S. enrollment for the GORE VIAFORT Vascular Stent IVC study
Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
Mar 27, 2023: Scientia Vascular receives additional 510(k) clearance for Volo 14 Guidewire
Mar 26, 2023: Scientia Vascular receives additional 510(k) clearance for Aristotle Colossus Guidewire
Mar 26, 2023: Scientia Vascular receives additional 510(k) clearance for Zoom 14 Guidewire
Mar 22, 2023: Two-Year study data for EVBA procedure with Unique MobiusHD device presented at Technology and Heart Failure Therapeutics Meeting
Mar 22, 2023: Vitrolife Notice to attend the Annual General Meeting
Mar 21, 2023: Tissue Regenix Group Announces Final results for the year ended 31 December 2022
Mar 16, 2023: Embolx signs international distribution agreement
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Mar 14, 2023: Shockwave Medical announces U.S. launch of new peripheral IVL Catheter
Mar 14, 2023: PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
Mar 13, 2023: Vivasure Medical announces FDA IDE approval to initiate U.S. pivotal study
Mar 10, 2023: Ossur Announces Results of the Annual General Meeting
Feb 28, 2023: Ultrasound device may offer new treatment option for hypertension
Feb 27, 2023: Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 23, 2023: LeMaitre Q4 2022 Financial Results
Feb 22, 2023: Shape Memory Medical announces first patient treated in the EMBO-post market surveillance registry in Germany
Feb 21, 2023: Biotronik receives 510(k) clearance for Passeo-35 Xeo PTA Balloon Catheter
Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
Feb 17, 2023: Ossur Announces Annual General Meeting
Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
Feb 14, 2023: BIOTRONIK announces its latest innovation: Oscar Multifunctional Peripheral Catheter
Feb 14, 2023: Asahi Intecc Announces Consolidated Financial Results for the Six Months Ended December 31, 2022
Feb 13, 2023: FDA grants IDE approval for Concept Medical’s Coated Balloon
Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Fullyear Forecasts for Fiscal 2023
Feb 10, 2023: AnGes Co. Announces Consolidated financial results for the fiscal year ending December 2022
Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
Feb 07, 2023: Boston Scientific receives additional 510(k) clearance for iSLEEVE Introducer Set
Feb 07, 2023: Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Feb 07, 2023: Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
Feb 06, 2023: Surmodics Lays off 58 employees
Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
Feb 02, 2023: CR Bard receives 510(k) clearance for Highlander 014 PTA Balloon Dilatation Catheter
Feb 02, 2023: Allegra Orthopaedics : Business update to the market
Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
Jan 31, 2023: Tractus Vascular receives 510(k) clearance for Tunnel Crossing Catheter
Jan 31, 2023: Merit Medical Systems receives 510(k) clearance for Low Profile Companion Sheath
Jan 31, 2023: Cagent Vascular announces superior lumen gain, greater volumetric blood flow using Serration Angioplasty: A sub-analysis of the PRELUDE BTK study
Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders
Jan 31, 2023: Inari Medical to Participate Virtually at the BTIG MedTech Digital Health Life Science & Diagnostic Tools Conference
Jan 31, 2023: Daiichi Sankyo Announces Consolidated Financial Results for the First Nine Months of the Year Ending March 31,2023
Jan 30, 2023: Omron Healthcare Announcement of Appointments of Directors and Executive Officers
Jan 19, 2023: Inari Medical obtains additional 510(k) clearance for Artix Ballon Guiding Sheath
Jan 19, 2023: Differentiated capabilities of Surmodics’ crystalline drug release platform for sirolimus-coated balloons presented at ISET conference
Jan 19, 2023: Surmodics provides regulatory update related to its FDA premarket approval application for the SurVeil Drug-Coated Balloon
Jan 18, 2023: First patient treated and enrolled in Terumo Medical’s Osprey Iliac IDE clinical trial
Jan 17, 2023: Ossur Announces Conference Call Tuesday 31 January at 9:00 CET
Jan 16, 2023: Surmodics announces SWING trial 12-month data to be presented at ISET conference on January 18
Jan 12, 2023: OpSens Announces Record First Quarter fiscal 2023 Financial Results
Jan 10, 2023: Instylla announces enrollment of initial patient in the prospective multicenter “HALT” study
Jan 10, 2023: MedAlliance's SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB approval
Jan 10, 2023: Fluidx unveils new embolic for neurovascular use
Jan 10, 2023: Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
Jan 10, 2023: Vygon Group appoints Ludovic Richard-Vitton as CEO
Jan 09, 2023: Alucent Biomedical Announces First Patient Enrolled in the First-In-Human Clinical Trial of Its Novel Alucentnvs Technology for Arteriovenous Fistula (AVF) In People With End Stage Renal Disease (ESRD)
Jan 09, 2023: Professor Tomás Ward appointed Director of Insight SFI Research Centre for Data Analytics at Dublin City University
Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
Jan 03, 2023: MicroVention receives 510(k) clearance for AZUR HydroPack 18
Jan 03, 2023: LimFlow receives 510(k) clearance for LimFlow Vector (Valvulotome)
Jan 03, 2023: ReCor Medical names Lara Barghout President and Chief Executive Officer
Dec 20, 2022: Balt USA receives additional FDA 510(k) clearance for Optima Coil System